Piramal Finance Q3FY26 Results: Profit Up, Revenue Grows to ₹2,917 Crore
Piramal Finance reported Q3FY26 profit of ₹401 crore on revenue of ₹2,917 crore. For nine months, profit was ₹1,004 crore on revenue of ₹8,428 crore. The company is selling its stake in Shriram Life Insurance for ₹600 crore, expected to close by March 31, 2026. Financials reflect a recent amalgamation.
The announcement includes the company's quarterly financial results, which are material to investors. Additionally, the sale of a significant stake in an associate company is a major corporate action with a considerable financial impact.
The company reported an increase in profit and revenue for the quarter and nine months ended December 31, 2025, compared to the previous year. The sale of a stake in Shriram Life Insurance also indicates a strategic move to unlock value.
Piramal Finance Limited announced its Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended December 31, 2025. The company's Board of Directors approved these results on January 23, 2026.
For the third quarter of FY26, Piramal Finance reported a total income of ₹2,975.09 crore, with revenue from operations standing at ₹2,917.68 crore. The profit for the period was ₹401.01 crore, and total comprehensive income was ₹398.45 crore. Earnings per share (EPS) for the quarter were ₹17.69 on a basic basis and ₹17.50 on a diluted basis.
Over the nine-month period ended December 31, 2025, the company achieved a total income of ₹8,565.47 crore and revenue from operations of ₹8,428.48 crore. The profit for this period was ₹1,004.37 crore, with total comprehensive income at ₹942.07 crore. The basic and diluted EPS for the nine months were ₹44.34 and ₹43.87, respectively.
The financial results reflect the impact of the Composite Scheme of Arrangement between Piramal Finance Limited and its holding company, Piramal Enterprises Limited (PEL), which became effective on September 16, 2025. Comparative figures have been restated to account for this amalgamation, which was treated as a reverse acquisition.
Notable items in the financial disclosures include amalgamation-related costs and compensation for tax matters of an erstwhile subsidiary, amounting to ₹59 crore and ₹22 crore, respectively, for the nine-month period. The company also recognized deferred tax assets of ₹2,740.32 crore as of December 31, 2025.
In a significant development, Piramal Finance has entered into a share purchase agreement to sell its 14.72% equity stake in Shriram Life Insurance Company Ltd for ₹600 crore. This transaction is expected to close in the quarter ending March 31, 2026, subject to regulatory approvals.
The company also disclosed its debt-equity ratio of 2.71 and total debts to total assets ratio of 0.72 as of December 31, 2025. The secured listed non-convertible debentures outstanding amounted to ₹28,764.61 crore.
What to do with a filing like this
Piramal Finance Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Piramal Finance Limited. Read the original for the full detail.